PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study

Abstract

RUD) instrument. 2010 unit costs per country were applied. RESULTS:The study cohort included 1497 AD patients (38% mild, 32% moderate and 31% severe AD) and their caregivers (nϭ419 France, nϭ552 Germany and nϭ526 UK) with a mean (SD) patient age of 79.4 (6.8) France, 75.2 (7.6) Germany, 78.5 (7.8) UK and 62% females in France, 50% Germany, 54% UK. One or more nights in hospital were recorded for 4% of patients in France, 7% Germany, 1% UK. One or more outpatient visits (including GP visits) were recorded for 84% of patients in France, 86% Germany, 73% UK. Total mean (SD) patient health care costs were €407 (970) in France, €570 (1618) in Germany, €197 (312) in the UK. Overall mean (SD) caregiver time spent on patients was highest in the UK 208.2 (189.8) hours per month [170.1 (184.8) France and 180.0 (198.4) Germany]. CONCLUSIONS: Health care resource use in the month prior to baseline was lower than expected. The UK had the fewest patients with nights spent in hospital and outpatient visits but total caregiver time was highest. Understanding differences in resource utilisation patterns between countries is necessary when examining cost of illness in AD.

Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America

“…A total of 47 studies reported economic data on the direct and indirect costs of AD for the seven selected countries; the remaining five studies reported aggregated international data [50][51][52][53][54]. Among the 47 studies, 17 primary source articles were identified in which cost component data were available and presented according to AD severity or patients' living conditions; two for France [55,56], four for Germany [7,[57][58][59], zero for Italy, three for the Netherlands [8,51,60], four for Spain [49,[61][62][63], two for the UK [64,65], and two for the USA [9,66].…”